Eimear Lagan
@eimearlagan.bsky.social
54 followers 96 following 13 posts
Post-doc @ IGC, University of Edinburgh Epigenetics | Paediatric cancer | Functional genomics
Posts Media Videos Starter Packs
Pinned
eimearlagan.bsky.social
Excited to share our new paper out today in @cp-molcell.bsky.social! We show that the H3K27M oncohistone rewires cPRC1, creating a unique dependency on CBX4/PCGF4-containing complexes, and also reveal a previously unknown function of CBX4. Highlights below (1/11).
Reposted by Eimear Lagan
peterlewislab.bsky.social
We are excited to share our new preprint demonstrating that nucleic acid interactions with SUZ12 constrain PRC2 activity, establishing a kinetic buffer essential for targeted gene silencing and revealing vulnerabilities in diffuse midline gliomas.
www.biorxiv.org/content/10.1...
eimearlagan.bsky.social
Thank you for your lovely preview of our work! 😄
eimearlagan.bsky.social
Thank you Elena! Congrats on your recent Mol Cell paper too 🥳 Hope you’re well!
eimearlagan.bsky.social
IP-mass spec revealed CBX4 preferentially forms a distinct complex with essential PCGF4. CBX2 lacks this specificity. Deleting the key disordered region shifts complex composition – the PCGF4 preference is lost, mimicking CBX2. This region defines CBX4’s unique function. (10/11)
eimearlagan.bsky.social
But what makes CBX4 so unique? We used a CRISPR tiling screen to pinpoint key domains. Result: the chromodomain (H3K27me3 binding) and a section of the central disordered region are essential for function. The chromodomain makes sense - what about that disordered part? (9/11)
eimearlagan.bsky.social
CUT&RUN-Rx says no - all forms of cPRC1 are displaced equally by PRC2i. Still, part of our hypothesis held: CBX4-cPRC1 drives repression of key genes, like p16-INK4A. KO of CBX4 derepressed genes, while KO of abundant CBX2/CBX8 had no significant impact on gene expression! (8/11)
eimearlagan.bsky.social
H3K27me3 retention and CBX4-cPRC1 accumulation at Polycomb target genes correlates with stronger gene repression in DMG. PRC2 inhibition derepresses target genes and DMG is sensitive to this. We thought: could PRC2 inhibition work by selectively displacing CBX4-cPRC1? (7/11)
eimearlagan.bsky.social
To dig deeper, we used CUT&RUN-Rx to map cPRC1 complexes in isogenic DMG cells with or without H3K27M. Strikingly, H3K27M rewires cPRC1 binding, driving CBX2/CBX4 accumulation and displacing CBX8 from CGIs at Polycomb targets genes. (6/11)
eimearlagan.bsky.social
This was surprising because paralogs like PCGF2, CBX2 and CBX8 are also expressed!
Mass spec revealed CBX4 is <5% of the CBX pool in DMG cells, while non-essential CBX2 and CBX8 are far more abundant. Yet, it’s this tiny CBX4-cPRC1 minority that’s functionally essential! (5/11)
eimearlagan.bsky.social
What about canonical PRC1? cPRC1 complexes bind H3K27me3 via the CBX subunit to repress gene expression. Our CRISPR-Cas9 screens in patient-derived DMG lines showed that only 2 specific cPRC1 components - CBX4 and PCGF4 (aka BMI1) - are functionally essential in DMG. (4/11)
eimearlagan.bsky.social
It was known that while H3K27M inhibits PRC2, residual H3K27me3 at CGIs is crucial for repressing oncogenic programs in DMG. We built on this by showing that while all PRC2 component combinations exist in DMG cells, only the catalytic core is essential for disease biology. (3/11)
eimearlagan.bsky.social
First, this was a collaborative effort that would not have been possible without super talented co-first author @dairegannon.bsky.social, co-senior authors Dr Richard Phillips, @adrianbracken.bsky.social & @gerrybrien.bsky.social. Thanks to many other international collaborators too! (2/11)
eimearlagan.bsky.social
Excited to share our new paper out today in @cp-molcell.bsky.social! We show that the H3K27M oncohistone rewires cPRC1, creating a unique dependency on CBX4/PCGF4-containing complexes, and also reveal a previously unknown function of CBX4. Highlights below (1/11).